OR WAIT null SECS
Topical eye treatments can be beneficial for patients with a growing array of eye diseases, but only if taken appropriately.
Inhaled vaccines must resist degradation and penetrate the mucosal lining in the airways and lungs.
May 19, 2023
Shabbir Mostafa, head of Business Development — Advanced Delivery Systems, Recipharm, sat down with Grant Playter, associate editor, during DCAT week to discuss the current state of inhalations forms and drug delivery.
May 18, 2023
Jane True, vice-president of mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer, shares her perspective on how mRNA will shift commercial models in the pharmaceutical industry.
Sania Therapeutics has emerged from stealth mode and launched its technology platforms for enabling the development of novel therapeutics to treat neural circuit dysfunction.
Gilead Sciences and Arcus Biosciences have expanded their research collaboration to include inflammatory diseases in addition to oncology.
May 17, 2023
Webinar Date/Time: Wed, Jun 14, 2023 11:00 AM EDT
May 16, 2023
Under the collaboration, BiOneCure Therapeutics and Nanjing Leads Biolabs intend to develop a range of innovative antibody-drug conjugates for treating solid tumors.
Webinar Date/Time: Wednesday May 31, 2023 at 11am EDT | 10am CDT | 8am PDT
Webinar Date/Time: Tuesday June 13, 2023 at 11 am EDT | 4pm BST | 5pm CEST
May 12, 2023
Dr. Ulrike Lemke, Head of Sterile Fill Finish at Recipharm, sat down with Grant Playter, associate editor, to discuss drug delivery forms.
Webinar Date/Time: Wed, May 24, 2023 2:00 PM EDT